Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)

CAPS Rating: 2 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

0
Player Avatar NVR2LATE4MONEY (< 20) Submitted: 12/6/2007 4:02:19 PM : Outperform Start Price: $28.25 AUXL Score: -23.21

Auxl has a hot pipeline

Featured Broker Partners


Advertisement